Suppression of the FA pathway combined with CHK1 inhibitor hypersensitize lung cancer cells to gemcitabine

The combination of platinum and gemcitabine is one of the standard regimens in the treatment of advanced lung squamous carcinoma (LSC). Resistance to gemcitabine is main barrier to the successful treatment of LSC. In this study, we showed that suppression of the Fanconi anemia (FA) pathway increased...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Chun-Hua, Wang, Yi, Chen, Ping, Jiang, Qian, Lan, Ting, Li, Mei-Yu, Su, Jin-Yu, Wu, Yan, Li, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678185/
https://www.ncbi.nlm.nih.gov/pubmed/29118324
http://dx.doi.org/10.1038/s41598-017-15172-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678185/
https://www.ncbi.nlm.nih.gov/pubmed/29118324
http://dx.doi.org/10.1038/s41598-017-15172-4

Ejemplares similares